The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
Open accessAbstract
Tumour hypoxia is increasingly recognized as a major deleterious factor in cancer therapies, as it compromises treatment and drives malignant progression. This review seeks to clarify the oxygen levels that are pertinent to this issue. It is argued that normoxia (20% oxygen) is an extremely poor comparator for "physoxia", i.e. the much lower levels of oxygen universally found in normal tissues, which averages about 5% oxygen, and ranges from about 3% to 7.4%. Importantly, it should be recognized that the median oxygenation in untreated tumours is significantly much lower, falling between approximately 0.3% and 4.2% oxygen, with most tumours exhibiting median oxygen levels <2%. This is partially dependent on the tissue of origin, and it is notable that many prostate and pancreatic tumours are profoundly hypoxic. In addition, therapy can induce even further, often unrecognized, changes in tumour oxygenation that may vary longitudinally, increasing or decreasing during treatment in ways that are not always predictable. Studies that fail to take cognizance of the actual physiological levels of oxygen in tissues (approximately 5%) and tumours (approximately 1%) may fail to identify the real circumstances driving tumour response to treatment and/or malignant progression. This can be of particular importance in genetic studies in vitro when comparison to human tumours is required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reduced oxygen tension activates a conserved hypoxic signaling network centered on hypoxia-inducible factors (HIFs)”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nevertheless, both physiological and pathological states can transiently disrupt the equilibrium between oxygen supply and demand, resulting in tissue and cellular hypoxia”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In liver metastases of colorectal cancer, the median PO2 was 6 mmHg as compared with 30 mmHg in normal liver tissue (20).”
From HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy (2022) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“This response features extensive transcriptional reprogramming aimed at preserving cellular integrity under low-oxygen conditions”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Radiobiology for the Radiologist.
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-3-438_1 · Cited by 3,498
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662
Pàez‐Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Viñals, F., Inoue, M., Bergers, G., Hanahan, D., & Casanovas, O. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.027 · Cited by 2,373
Research works printed but not linked: 8
- Vaupel P, 2010, Exp Oncol, 32, 125
- Vaupel P, 2003, Cancer Res, 63, 7634
- Höckel M, 1991, Cancer Res, 51, 6098
- Kallinowski F, 1995, Tumor oxygenation, 291
- Kallinowski F, 1995, Tumor oxygenation, 205
- Vaupel P, 2006, Eur J Gynaecol Oncol, 27, 142
- Stone JE, 2005, Eur J Gynaecol Oncol, 26, 31
- Cairns RA, 2001, Cancer Res, 61, 8903
Cited by
Sorted by citations
Items 301–400 of 1,000
BACH1, the master regulator of oxidative stress, has a dual effect on CFTR expression
NandyMazumdar, M., Paranjapye, A., Browne, J. A., Yin, S., Leir, S., & Harris, A. (2021) · Biochemical Journal · doi:10.1042/bcj20210252 · Cited by 28
Pierce, K. M., Miklavcic, W. R., Cook, K. P., Hennen, M. S., Bayles, K. W., Hollingsworth, M. A., Brooks, A. E., Pullan, J. E., & Dailey, K. M. (2021) · Nanomaterials · doi:10.3390/nano11113018 · Cited by 30
Zhang, S., Chen, H., Wang, L., Qin, X., Jiang, B., Ji, S., Shen, X., & Liang, H. (2021) · Angewandte Chemie · doi:10.1002/ange.202107076 · Cited by 28
Hepatic Stellate Cells in Liver Tumor
Shiraha, H., Iwamuro, M., & Okada, H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-37184-5_4 · Cited by 27
Nesbitt, H., Byrne, N. M., Williams, S. N., Ming, L., Worthington, J., Errington, R. J., Patterson, L. H., Smith, P. J., McKEOWN, S. R., & McKenna, D. J. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1361 · Cited by 26
Self-citationWieczorek-Szweda, E., Młynarczyk, D. T., Kucińska, M., Długaszewska, J., Piskorz, J., Popenda, Ł., Szczołko, W., Jurga, S., Murias, M., Mielcarek, J., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.064 · Cited by 27
Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer
Taneja, S., Vetter, S. W., & Leclerc, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158153 · Cited by 28
Celora, G. L., Byrne, H. M., & Kevrekidis, P. G. (2022) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2022.111248 · Cited by 27
Mg-based materials diminish tumor spreading and cancer metastases
Globig, P., Madurawala, R., Willumeit‐Römer, R., Martini, F., Mazzoni, E., & Luthringer-Feyerabend, B. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.05.002 · Cited by 27
Drug Resistance: The Role of Exosomal miRNA in the Microenvironment of Hematopoietic Tumors
Cariello, M., Squilla, A., Piacente, M., Venutolo, G., & Fasano, A. (2022) · Molecules · doi:10.3390/molecules28010116 · Cited by 28
Shen, X., & Gates, K. S. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00036 · Cited by 28
Hypoxia differentially regulates estrogen receptor alpha in 2D and 3D culture formats
Whitman, N. A., Lin, Z.-W., Kenney, R. M., Sanchez, L. A., & Lockett, M. R. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.05.025 · Cited by 28
Regulation of the HIF switch in human endothelial and cancer cells
Slawski, J., Jaśkiewicz, M., Barton, A., Kozioł, S., Collawn, J. F., & Bartoszewski, R. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151386 · Cited by 26
Mitochondria as disease-relevant organelles in rheumatoid arthritis
Weyand, C. M., Wu, B., Huang, T., Hu, Z., & Goronzy, J. J. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac107 · Cited by 29
Kumar, A., Goudar, V. S., Nahak, B. K., Tsai, P., Lin, H., & Tseng, F. (2023) · Small · doi:10.1002/smll.202307955 · Cited by 27
(Single-stranded DNA) gaps in understanding BRCAness
Schreuder, A., Wendel, T. J., Dorresteijn, C. G. V., & Noordermeer, S. M. (2024) · Trends in Genetics · doi:10.1016/j.tig.2024.04.013 · Cited by 25
Physicochemical Modulation Strategies for Mass Production of Extracellular Vesicle
Park, H., Seo, Y., Arai, Y., & Lee, S. (2025) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-025-00726-9 · Cited by 28
Hawke, L. G., Whitford, M. K., & Ormiston, M. L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01903 · Cited by 30
Heble, A. Y., Santelli, J., Armstrong, A. M., Mattrey, R. F., & Lux, J. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c19633 · Cited by 26
Wegge, M., Dok, R., & Nuyts, S. (2021) · Cancers · doi:10.3390/cancers13235959 · Cited by 27
Arora, L., Patra, D., Roy, S., Nanda, S., Singh, N., Verma, A. K., Chakraborti, A., Dasgupta, S., & Pal, D. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13260 · Cited by 26
Papakonstantinou, A., Koumarianou, P., Rigakou, A., Diamantakos, P., Frakolaki, E., Vassilaki, N., Chavdoula, E., Melliou, E., Magiatis, P., & Boleti, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010003 · Cited by 26
Zaarour, R. F., Ribeiro, M., Azzarone, B. G., Kapoor, S., & Chouaı̈b, S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1222575 · Cited by 25
Duś‐Szachniewicz, K., Drobczyński, S., Ziolkowski, P. P., Kołodziej, P., Walaszek, K., Korzeniewska, A. K., Agrawal, A. K., Kupczyk, P., & Woźniak, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071880 · Cited by 25
Seok, J., Yoon, S., Lee, S., Jung, J. H., & Lee, Y. M. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4649 · Cited by 24
Osrodek, M., Hartman, M. L., & Czyż, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174203 · Cited by 27
The Metabolic Features of Tumor-Associated Macrophages: Opportunities for Immunotherapy?
Mojsilović, S. S., Mojsilović, S. B., Villar, V. H., & Santibanez, J. F. (2021) · Analytical Cellular Pathology · doi:10.1155/2021/5523055 · Cited by 26
Valente, R., Cordeiro, S. Z., Luz, A., Melo, M. C., Roma‐Rodrigues, C., Baptista, P. V., & Fernandes, A. R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1310397 · Cited by 25
Hypoxia switches TET1 from being tumor-suppressive to oncogenic
Yang, Q., Dang, H., Liu, J., Wang, X., Wang, J., Lan, X., Ji, M., Xing, M., & Hou, P. (2023) · Oncogene · doi:10.1038/s41388-023-02659-w · Cited by 24
Mitochondrial metabolism regulation and epigenetics in hypoxia
Laird, M., Ku, J. C., Raiten, J., Sriram, S., Moore, M., & Li, Y. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1393232 · Cited by 26
Srinivasarao, D. A., Shah, S., Famta, P., Vambhurkar, G. B., Jain, N., Pindiprolu, S. K. S. S., Sharma, A., Kumar, R., Padhy, H. P., Kumari, M., et al. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01673-z · Cited by 25
Harnessing hypoxia as an evolutionary driver of complex multicellularity
Hammarlund, E. U. (2020) · Interface Focus · doi:10.1098/rsfs.2019.0101 · Cited by 25
Hsu, H., Ko, P., Wu, H., Lin, H., Wang, C., & Tung, Y. (2021) · Small · doi:10.1002/smll.202006091 · Cited by 24
Flexible thread-based electrochemical sensors for oxygen monitoring
Xia, J., & Sonkusale, S. (2021) · The Analyst · doi:10.1039/d0an02400g · Cited by 24
Hypoxia and HIFs in Ewing sarcoma: new perspectives on a multi-facetted relationship
Ceranski, A. K., Carreño-Gonzalez, M. J., Ehlers, A. C., Colombo, M. V., Cidre‐Aranaz, F., & Grünewald, T. G. P. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01750-w · Cited by 25
Wolska, N., Celikag, M., Failla, A. V., Tarafdar, A., Renné, T., Torti, M., Canobbio, I., & Pula, G. (2023) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2023.100154 · Cited by 24
Microbial‐Enabled Photosynthetic Oxygenation for Disease Treatment
Yang, Z., Li, P., Feng, W., & Chen, Y. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202305866 · Cited by 26
Current challenges and opportunities in treating hypoxic prostate tumors
McKenna, D. J., Errington, R. J., & Pors, K. (2018) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2017.54 · Cited by 25
Maurer, G. D., Heller, S., Wanka, C., Rieger, J., & Steinbach, J. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051061 · Cited by 24
Mathur, S., Chen, S., & Rejniak, K. A. (2024) · npj Systems Biology and Applications · doi:10.1038/s41540-023-00327-z · Cited by 23
Wang, J., Wang, J., Yu, Z., Wen, H., Zhao, C.-S., Zhong, J., Xiao, C., Li, Y., Xu, J., Wang, J., et al. (2025) · Advanced Science · doi:10.1002/advs.202411813 · Cited by 25
Cycling hypoxia selects for constitutive HIF stabilization
Pressley, M., Gallaher, J. A., Brown, J. S., Tomaszewski, M. R., Borad, P., Damaghi, M., Gillies, R. J., & Whelan, C. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-85184-8 · Cited by 23
Tissue Nutrient Environments and Their Effect on Regulatory T Cell Biology
Blagih, J., Hennequart, M., & Zani, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637960 · Cited by 25
Birindelli, G., Drobnjaković, M., Morath, V., Steiger, K., D’Alessandria, C., Gourni, E., Afshar‐Oromieh, A., Weber, W., Rominger, A., Eiber, M., et al. (2021) · Cancers · doi:10.3390/cancers13143429 · Cited by 23
Immunotherapeutic targets in non‐small cell lung cancer
Sadeghirad, H., Bahrami, T., Layeghi, S. M., Yousefi, H., Rezaei, M., Hosseini‐Fard, S. R., Radfar, P., Warkiani, M. E., O'Byrne, K. J., & Kulasinghe, A. (2022) · Immunology · doi:10.1111/imm.13562 · Cited by 24
Hanley, R., Pagliari, F., García-Calderón, D., Guerreiro, J. F., Genard, G., Jansen, J., Nisticò, C., Marafioti, M. G., Tirinato, L., & Seco, J. C. (2023) · Radiation Oncology · doi:10.1186/s13014-023-02275-8 · Cited by 24
Kokeza, J., Strikić, A., Ogorevc, M., Kelam, N., Vukoja, M., Dilber, I., & Tomaš, S. Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310575 · Cited by 23
Kefayat, A., Ghahremani, F. H., Motaghi, H., Rostami, S., & Mehrgardi, M. A. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1523417 · Cited by 23
Matsuyama, M., WuWong, D. J., Horvath, S., & Matsuyama, S. (2019) · Aging · doi:10.18632/aging.101955 · Cited by 24
Szewczyk, G. M., Mokrzynski, K. T., & Sarna, T. (2024) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-024-00620-8 · Cited by 22
UVC-Emitting LuPO4:Pr3+ Nanoparticles Decrease Radiation Resistance of Hypoxic Cancer Cells
Müller, M., Espinoza, S., Jüstel, T., Held, K. D., Anderson, R. R., & Purschke, M. (2019) · Radiation Research · doi:10.1667/rr15491.1 · Cited by 22
Li, C., Humayun, M., Walker, G. M., Park, K. Y., Connors, B., Feng, J., Pellitteri-Hahn, M. C., Scarlett, C. O., Li, J., Feng, Y., et al. (2022) · Advanced Science · doi:10.1002/advs.202104510 · Cited by 22
Ishkaeva, R. A., Zoughaib, M., Laikov, A. V., Angelova, P. R., & Abdullin, T. I. (2022) · Antioxidants · doi:10.3390/antiox11020391 · Cited by 23
Recapitulating Tumor Hypoxia in a Cleanroom-Free, Liquid-Pinning-Based Microfluidic Tumor Model
Oh, J. M., Begum, H. M., Liu, Y. L., Ren, Y., & Shen, K. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00207 · Cited by 22
The role of tumor‐associated macrophages in hepatocellular carcinoma progression: A narrative review
Zhang, X., Yu, C., Zhao, S., Wang, M., Shang, L., Zhou, J., & Ma, Y. (2023) · Cancer Medicine · doi:10.1002/cam4.6717 · Cited by 24
Stimuli-Responsive Polymeric Nanomedicine for Enhanced Cancer Immunotherapy
Kim, C. H., Lee, E. S., Ko, H., Son, S., Kim, S. H., Lee, C. H., Na, H., Shin, J. M., & Park, J. H. (2024) · Chemistry of Materials · doi:10.1021/acs.chemmater.3c02472 · Cited by 22
Metabolic Potential of Cancer Cells in Context of the Metastatic Cascade
Benzarti, M., Delbrouck, C., Neises, L., Kiweler, N., & Meiser, J. (2020) · Cells · doi:10.3390/cells9092035 · Cited by 21
Motealleh, A., Schäfer, A. H., Fromm, O., & Kehr, N. S. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.1c01067 · Cited by 22
Kumano, K., Nakahashi, H., Louphrasitthiphol, P., Kuroda, Y., Miyazaki, Y., Shimomura, O., Hashimoto, S., Akashi, Y., Mathis, B. J., Kim, J., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1327772 · Cited by 21
Transcription Factors and Methods for the Pharmacological Correction of Their Activity
Guryanova, S. V., Maksimova, T. V., & Мухамедовна, А. М. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136394 · Cited by 23
Foglia, B., Sutti, S., Cannito, S., Rosso, C., Maggiora, M., Autelli, R., Novo, E., Bocca, C., Villano, G., Ramavath, N. N., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.10.002 · Cited by 22
Ahmed, M. A. M., & Nagelkerke, A. (2021) · Organs-on-a-Chip · doi:10.1016/j.ooc.2021.100012 · Cited by 24
Onken, M. D., Noda, S. E., Kaltenbronn, K. M., Frankfater, C., Makepeace, C. M., Fettig, N., Piggott, K., Custer, P. L., Ippolito, J. E., & Blumer, K. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101495 · Cited by 21
MiR-21 Is Induced by Hypoxia and Down-Regulates RHOB in Prostate Cancer
Angel, C. Z., Stafford, M. Y. C., McNally, C. J., Nesbitt, H., & McKenna, D. J. (2023) · Cancers · doi:10.3390/cancers15041291 · Cited by 22
Targeting Active Cancer Cells With Smart Bullets
Martel, S. M. (2017) · Therapeutic Delivery · doi:10.4155/tde-2016-0088 · Cited by 21
Hypoxia-activated pro-drugs of the KDAC inhibitor vorinostat (SAHA)
Calder, E. D. D., Skwarska, A., Sneddon, D., Folkes, L. K., Mistry, I. N., Conway, S. J., & Hammond, E. M. (2020) · Tetrahedron · doi:10.1016/j.tet.2020.131170 · Cited by 21
Juhász, K. Z., Hajdú, T., Kovács, P., Vágó, J., Matta, C., & Takács, R. (2024) · Cells · doi:10.3390/cells13060512 · Cited by 20
3D stem-like spheroids-on-a-chip for personalized combinatorial drug testing in oral cancer
Mehta, V., Sudhakaran, S. V., Nellore, V., Madduri, S., & Rath, S. N. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02625-y · Cited by 21
Extracellular vesicles and the tumour microenvironment
Belényesi, S.-K., Patmore, S., & O’Driscoll, L. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189275 · Cited by 20
Role of hyperoxic treatment in cancer
Kim, S. W., Kim, I. K., & Lee, S. H. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220921547 · Cited by 20
Mu, H., Ge, Y. P., Li, H., Wang, M., Cui, Y., Zhang, T., Song, T., & Liu, C. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00625-w · Cited by 23
Ryniawec, J. M., Coope, M. R., Loertscher, E., Bageerathan, V., Pessôa, D. D. O., Warfel, N. A., Cress, A. E., Padi, M., & Rogers, G. C. (2022) · Diagnostics · doi:10.3390/diagnostics12030676 · Cited by 20
Gong, W., Guo, Y., Yuan, H., Chai, R., Wan, Z., Zheng, B., Hu, X., Chen, B., Gao, S., Dai, Q., et al. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00591-5 · Cited by 23
Samuel, T., Rapic, S., O’Brien, C., Edson, M., Zhong, Y., & DaCosta, R. S. (2023) · Science Advances · doi:10.1126/sciadv.ade8672 · Cited by 20
Jiang, H., Ning, G., Wang, Y., & Lv, W. (2020) · Europe PMC (PubMed Central) · Cited by 20
Analysis of the Internal Hypoxic Environment in Solid Tumor Tissue Using a Folding Paper System
Huang, C., Chong, K., & Lei, K. F. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c08857 · Cited by 20
Hypoxia modulates CCR7 expression in head and neck cancers
Basheer, H. A., Pakanavicius, E., Cooper, P. A., Shnyder, S. D., Martin, L., Hunter, K. D., Vinader, V. M., & Afarinkia, K. (2018) · Oral Oncology · doi:10.1016/j.oraloncology.2018.03.014 · Cited by 22
Dal Molin, M., Brant, A., Blackford, A. L., Griffin, J. F., Shindo, K., Barkley, T., Rezaee, N., Hruban, R. H., Wolfgang, C. L., & Goggins, M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0164195 · Cited by 19
Patient-specific prostate tumour growth simulation: a first step towards the digital twin
Pérez-Benito, Á., García‐Aznar, J. M., Gómez‐Benito, M. J., & Pérez, M. Á. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1421591 · Cited by 19
Growth and adaptation mechanisms of tumour spheroids with time-dependent oxygen availability
Murphy, R. J., Gunasingh, G. P., Haass, N. K., & Simpson, M. J. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010833 · Cited by 19
Generation of Human Blood Vessel Organoids from Pluripotent Stem Cells
Werschler, N., & Penninger, J. M. (2023) · Journal of Visualized Experiments · doi:10.3791/64715 · Cited by 19
Oxygen concentration modulates colibactin production
Bossuet‐Greif, N., Guyonnet, C., Chagneau, C. V., Tang-Fichaux, M., Pénary, M., Loubet, D., Branchu, P., Oswald, É., & Nougayrède, J. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2222437 · Cited by 21
Ježek, J., Plecitá‐Hlavatá, L., & Ježek, P. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00637 · Cited by 20
Carbonic anhydrase III is a new target of HIF1α in prostate cancer model
Okuyan, D., Türkoğlu, S. A., & KOCKAR, F. T. (2020) · Gene · doi:10.1016/j.gene.2020.145034 · Cited by 19
Altuntaş, C., Alper, M., Keleş, Y., Sav, F. N., & KOCKAR, F. T. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04549-3 · Cited by 19
Li, H., Zhang, X., Chen, S., Cao, C., Zhang, X., Li, X., Xing, S., Jia, S., Li, J., & Wang, S. (2024) · ACS Materials Letters · doi:10.1021/acsmaterialslett.4c00798 · Cited by 18
Bou-Gharios, J., Noël, G., & Burckel, H. (2024) · BMC Biology · doi:10.1186/s12915-024-02075-w · Cited by 18
Interaction of Artepillin C with model membranes: Effects of pH and ionic strength
Pazin, W. M., Ruiz, G. C. M., Oliveira, O. N., & Constantino, C. J. L. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.11.008 · Cited by 18
Ornell, K. J., Mistretta, K. S., Newman, E. A., Ralston, C. Q., & Coburn, J. M. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01267 · Cited by 18
Nursalim, Y. N. S., Blenkiron, C., Groom, K. M., & Chamley, L. W. (2020) · Reproduction · doi:10.1530/rep-19-0605 · Cited by 18
Zeng, Y., Nguyen, V. P., Li, Y., Kang, D. H., Paulus, Y. M., & Kim, J. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c02767 · Cited by 19
Dual-Mode Tumor Imaging Using Probes That Are Responsive to Hypoxia-Induced Pathological Conditions
Subasinghe, S. A. A. S., Pautler, R. G., Samee, M. A. H., Yustein, J. T., & Allen, M. J. (2022) · Biosensors · doi:10.3390/bios12070478 · Cited by 18
Kumar, N., Mondal, M., Arathi, B. P., Sundaresan, N. R., & Somasundaram, K. (2022) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2022.194900 · Cited by 19
Coates, H. W., Capell-Hattam, I. M., Olzomer, E. M., Du, X., Farrell, R., Yang, H., Byrne, F. L., & Brown, A. J. (2022) · eLife · doi:10.7554/elife.82843 · Cited by 22
Mathur, D., Liao, C., Lin, W., Ferlita, A. L., Alaimo, S., Taylor, S. R., Zhong, Y., Iacobuzio–Donahue, C. A., Ferro, A., & Xavier, J. B. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0153 · Cited by 18
Infantile Hemangioma: A Cross-Sectional Observational Study
Şandru, F., Turenschi, A., Constantin, A. T., Dinulescu, A., Radu, A.-M., & Roșca, I. (2023) · Life · doi:10.3390/life13091868 · Cited by 18
A Simplified Protocol to Induce Hypoxia in a Standard Incubator: A Focus on Retinal Cells
Kaur, B., Scavuzzi, B. M., Abcouwer, S. F., & Zacks, D. N. (2023) · Experimental Eye Research · doi:10.1016/j.exer.2023.109653 · Cited by 18
A Review of Advances in Mitochondrial Research in Cancer
Li, Z., Zhang, W., Guo, S., Qi, G., Huang, J., Gao, J., Zhao, J., Kang, L., & Li, Q. (2024) · Cancer Control · doi:10.1177/10732748241299072 · Cited by 22
FLASH Radiotherapy: Benefits, Mechanisms, and Obstacles to Its Clinical Application
Alhaddad, L., Osipov, A. N., & Leonov, S. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312506 · Cited by 22
Mechanisms and consequences of ATMIN repression in hypoxic conditions: roles for p53 and HIF-1
Leszczyńska, K. B., Göttgens, E., Biasoli, D., Olcina, M. M., Ient, J., Anbalagan, S., Bernhardt, S., Giaccia, A. J., & Hammond, E. M. (2016) · Scientific Reports · doi:10.1038/srep21698 · Cited by 21
Metadata
- Authors
- McKeown, S. R.
- Affiliations
- University of Ulster (GB)
- Corresponding author
- McKeown, S R
- Venue
- The British Journal of Radiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-03
- Volume
- 87
- Issue
- 1035
- Pages
- 20130676
- ISSN
- 0007-1285 (ISSN-L)
- 1748-880X
- PMC
- PMC4064601
- OpenAlex
- W2018722597
- Cited by
- 1,050
- References
- 126
- Citations by year
- 2026: 84 · 2025: 122 · 2024: 129 · 2023: 139 · 2022: 137 · 2021: 152 · 2020: 107 · 2019: 68 · 2018: 56 · 2017: 33 · 2016: 13 · 2015: 5 · 2014: 4
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Radiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- tumor hypoxia, tumor oxygenation, normoxia, treatment response, prostate cancer, pancreatic cancer, malignant progression
- MeSH terms
- Animals, Hypoxia, Humans, Male, Neoplasms, Oxygen, Cell Hypoxia, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review